Clinical Trials Browser

Phase 2 × Lymphoma, Mantle-Cell × tipifarnib × Clear all

Hodgkin Disease, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, T-Cell, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT00847223 2018-08-23

Efficacy and Safety of the Farnesyl-transferase Inhibitor (Tipifarnib) in Mantle Cell Lymphoma

Phase 2 Terminated

11 enrolled

Lymphoid

Lymphoma, Recurrence, Lymphoma, Mantle-Cell

Clinical Trials

Tipifarnib in Treating Patients With Relapsed or Refractory Lymphoma

Efficacy and Safety of the Farnesyl-transferase Inhibitor (Tipifarnib) in Mantle Cell Lymphoma